Get started
Author

Huaping Yang

Observed names: HUA-PING YANG, HUAPING YANG, Hua-Ping YANG, Hua-Ping Yang, Hua-ping Yang, Hua‐Ping Yang, Yang, Huaping
Institution: Nanchang University
OpenAlex ID: A5101110285
Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial
2024 · Ying Cheng, Jianhua Chen, et al. · Nature Medicine · 150
PDF
The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration® Valve System in the Treatment of Severe Emphysema
2018 · Shiyue Li, Guangfa Wang, et al. · Respiration · 95
PDF
MicroRNA-33b inhibits lung adenocarcinoma cell growth, invasion, and epithelial-mesenchymal transition by suppressing Wnt/β-catenin/ZEB1 signaling
2015 · JINGJING QU, MIN LI, et al. · International Journal of Oncology · 89
PDF
EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation
2016 · MIN LI, JING-JING LI, et al. · Oncology Reports · 45
PDF
Rnd3 Regulates Lung Cancer Cell Proliferation through Notch Signaling
2014 · Yongjun Tang, Chengping Hu, et al. · PLoS ONE · 37
PDF
Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
2023 · Yu Yao, Huaping Yang, et al. · Respiratory Research · 36
PDF
Myelomatous pleural effusion as an initial sign of multiple myeloma-a case report and review of literature.
2014 · Li-Li Zhang, Yuan-Yuan Li, et al. · PubMed · 33
Role of Ku70 and Bax in epigallocatechin-3-gallate-induced apoptosis of A549 cells in vivo
2012 · JING-JING LI, QI-HUA GU, et al. · Oncology Letters · 32
PDF
Association between eIF3α polymorphism and severe toxicity caused by platinum‐based chemotherapy in non‐small cell lung cancer patients
2012 · Xiaojing Xu, Lifang Han, et al. · British Journal of Clinical Pharmacology · 32
PDF
Snail1-expressing cancer-associated fibroblasts induce lung cancer cell epithelial-mesenchymal transition through miR-33b
2017 · Jia You, Min Li, et al. · Oncotarget · 30
PDF
Treatment with EGCG in NSCLC leads to decreasing intersti-tial fluid pressure and hypoxia to improve chemotherapy efficacy through rebalance of Ang-1 and Ang-2
2013 · Peng-Bo DENG, Cheng-Ping HU, et al. · Chinese Journal of Natural Medicines · 30
The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients
2012 · Xiaojing Xu, Lifang Han, et al. · Lung Cancer · 29
PDF
A Novel Electromagnetic Navigation Bronchoscopy System for the Diagnosis of Peripheral Pulmonary Nodules: A Randomized Clinical Trial
2022 · Xiaoxuan Zheng, Liming Cao, et al. · Annals of the American Thoracic Society · 28
Robotic-assisted thoracic surgery following neoadjuvant chemoimmunotherapy in patients with stage III non-small cell lung cancer: A real-world prospective cohort study
2022 · Yang Gao, Juan Jiang, et al. · Frontiers in Oncology · 27
PDF
Transforming growth factor-β-induced miR-143 expression in regulation of non-small cell lung cancer cell viability and invasion capacity in vitro and in vivo
2014 · TIANLI CHENG, CHENGPING HU, et al. · International Journal of Oncology · 27
PDF
Synthesis and investigations of ciprofloxacin loaded engineered selenium lipid nanocarriers for effective drug delivery system for preventing lung infections of interstitial lung disease
2019 · Jingjing Liu, Jie Meng, et al. · Journal of Photochemistry and Photobiology B Biology · 26
Serum IL-6 as a vital predictor of severe lung cancer
2021 · Jian An, Qihua Gu, et al. · Annals of Palliative Medicine · 25
Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma
2013 · Rong-li Lu, Cheng-Ping Hu, et al. · Pathology & Oncology Research · 25
The Predictive Values of Advanced Non-Small Cell Lung Cancer Patients Harboring Uncommon EGFR Mutations—The Mutation Patterns, Use of Different Generations of EGFR-TKIs, and Concurrent Genetic Alterations
2021 · Jiarong Tan, Chengping Hu, et al. · Frontiers in Oncology · 23
Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial
2023 · Shun Lu, Hongming Pan, et al. · Signal Transduction and Targeted Therapy · 21
PDF
Pirfenidone promotes the levels of exosomal miR-200 to down-regulate ZEB1 and represses the epithelial-mesenchymal transition of non-small cell lung cancer cells
2022 · Jingjing Liu, Liming Cao, et al. · Human Cell · 19
Abstract CT248: Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2 mutant non-small cell lung cancer (NSCLC): primary analysis from the Phase 2 DESTINY-Lung05 (DL-05) trial
2024 · Ying Cheng, Lin Wu, et al. · Cancer Research · 18
Epigallocatechin-3-gallate-induced vascular normalization in A549-cell xenograft-bearing nude mice: therapeutic efficacy in combination with chemotherapy
2019 · Pengbo Deng, ChengPing Hu, et al. · Cancer Management and Research · 18
PDF
β-hydroxybutyrate serves as a regulator in ketone body metabolism through lysine β-hydroxybutyrylation
2025 · Jie Fang, Zhenghui Hu, et al. · Journal of Biological Chemistry · 14
Safety and efficacy of anlotinib in combination with standard chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A multi-center, prospective study (ACTION-2)
2022 · Wei Zhang, Pengbo Deng, et al. · Lung Cancer · 13
Works count: 57
Citation count: 1,046
H-index: 20
I10-index: 27
Year
Topic
Type